Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study-Reference-Cited by-同舟云学术

Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study

Published:2017-01 Issue:1 Volume:4 Page:e24-e34
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Furman Richard R,Eradat Herbert A,DiRienzo Christine G,Hofmeister Craig C,Hayman Suzanne R,Leonard John P,Coleman Morton,Advani Ranjana,Chanan-Khan Asher,Switzky Julie,Liao Qiming M,Shah Damini,Jewell Roxanne C,Lisby Steen,Lin Thomas S

Publisher

Elsevier BV

Subject

Hematology

Reference28 articles.

1. Waldenström macroglobulinaemia;Ghobrial;Lancet Oncol,2003

2. Developing diagnostic criteria in Waldenstrom's macroglobulinemia;Owen;Semin Oncol,2003

3. Differential diagnosis of Waldenström's macroglobulinemia and other B-cell disorders;Pangalis;Clin Lymphoma,2005

4. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs;Leleu;J Clin Oncol,2009

5. Balancing risk versus benefit in the treatment of Waldenström's macroglobulinemia patients with nucleoside analogue-based therapy;Leleu;Clin Lymphoma Myeloma,2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-02

2. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-01

3. Waldenstrom Macroglobulinemia;Comprehensive Hematology and Stem Cell Research;2024

4. Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy;Hematology/Oncology Clinics of North America;2023-08

5. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria;Seminars in Hematology;2023-03